Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.00K | 25.90K | 1.90K | -- | 7.80K |
| Total Other Revenue | -- | 100.00 | 100.00 | -- | -- |
| Total Revenue | 11.00K | 26.00K | 2.00K | -- | 7.80K |
| Cost of Revenue | 87.10K | 99.40K | 75.00K | 96.80K | 98.40K |
| Gross Profit | -76.10K | -73.40K | -73.00K | -96.80K | -90.60K |
| SG&A Expenses | 2.03M | 1.78M | 1.47M | 1.51M | 1.18M |
| Depreciation & Amortization | 197.50K | 188.80K | 183.30K | 168.70K | 143.00K |
| Other Operating Expenses | -93.10K | -98.00K | -56.00K | -108.40K | -94.50K |
| Total Operating Expenses | 7.22M | 5.20M | 4.86M | 4.89M | 4.18M |
| Operating Income | -7.21M | -5.18M | -4.86M | -4.89M | -4.17M |
| Income Before Tax | -6.97M | -5.18M | -4.69M | -4.46M | -4.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.97M | -5.18M | -4.69M | -4.46M | -4.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.97M | -5.18M | -4.69M | -4.46M | -4.09M |
| EBIT | -7.21M | -5.18M | -4.86M | -4.89M | -4.17M |
| EBITDA | -7.01M | -4.99M | -4.69M | -4.72M | -4.01M |
| EPS Basic | -0.05 | -0.04 | -0.03 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Diluted | -0.05 | -0.04 | -0.03 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| Average Basic Shares Outstanding | 137.50M | 137.50M | 137.50M | 105.90M | 104.09M |
| Average Diluted Shares Outstanding | 137.50M | 137.50M | 137.50M | 105.90M | 104.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |